CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Delcath Systems

For profitWebsite ↗

Also known as: Delcath Systems Inc. | DELCATH SYSTEMS INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Dec 31, 2025

Timeline

1980s

Jun 1, 1987
Delcath Systems— Founded

2020s

Aug 14, 2023
melphalan— NDA Secondary Org

Drugs by trial phase (17 distinct, 12 trials)

Phase 3 (7 own, 0 via acquisition)

Phase 2 (10 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

melphalan

Recent trials (14)

NCT05022901Lead sponsorN/A—
NCT07276386CollaboratorPhase 2Dec 31, 2025
NCT07281924CollaboratorPhase 1/Phase 2Dec 31, 2025
NCT06875128Lead sponsorPhase 2Sep 30, 2025
NCT06607458Lead sponsorPhase 2May 31, 2025
NCT03086993Lead sponsorPhase 2/Phase 3Sep 1, 2017
NCT02678572Lead sponsorPhase 3Jan 1, 2015
NCT02406508Lead sponsorPhase 2Oct 1, 2014
NCT02406508Study directorPhase 2Oct 1, 2014
NCT02415036Study directorPhase 2Jun 1, 2014
NCT02415036Lead sponsorPhase 2Jun 1, 2014
NCT01728051Lead sponsorN/ANov 13, 2012
NCT00324727Lead sponsorPhase 3Feb 1, 2006
NCT00096083Lead sponsorPhase 2Sep 1, 2004

Details

Founded: New York, NY, US Jun 1, 1987
Last known activity: Dec 31, 2025